Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 7, 2012
- Accepted for publication June 18, 2012
- Published online November 1, 2012.
Article Versions
- previous version (October 12, 2012 - 08:15).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Amy L. Vāvere1,
- Elizabeth R. Butch1,
- Jason L.J. Dearling2,
- Alan B. Packard2,
- Fariba Navid3,
- Barry L. Shulkin1,
- Raymond C. Barfield4 and
- Scott E. Snyder1
- 1Division of Nuclear Medicine, Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee
- 2Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Children’s Hospital Boston and Harvard Medical School, Boston, Massachusetts
- 3Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee; and
- 4Division of Hematology-Oncology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina
- For correspondence or reprints contact: Scott E. Snyder, Department of Radiological Sciences, St. Jude Children’s Research Hospital, Mail Stop #220, 262 Danny Thomas Pl., Memphis, TN 38105. E-mail: scott.snyder{at}stjude.org
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors
- Ultrasensitive detection of malignant melanoma using PET molecular imaging probes
- N-(2-(Dimethylamino)Ethyl)-4-18F-Fluorobenzamide: A Novel Molecular Probe for High-Contrast PET Imaging of Malignant Melanoma
- Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma